Skip to content
10-Q

Quarterly Report

IRIS BIOTECHNOLOGIES INC

0001554795-15-000200

← back to feed
Filed
May 15, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · May 15, 2015 15.35M sh
Shares Diluted Q1 2015 · Mar 31, 2015 15.36M sh
Shares Diluted Q1 2015 · Mar 31, 2014 14.11M sh
Stockholders Equity Q1 2015 · Mar 31, 2015 −$1.76K
Stockholders Equity Q1 2015 · Dec 31, 2014 $63.6K
Current Liabilities Q1 2015 · Mar 31, 2015 $165.97K
Current Liabilities Q1 2015 · Dec 31, 2014 $242.21K
Total Liabilities Q1 2015 · Mar 31, 2015 $191.97K
Total Liabilities Q1 2015 · Dec 31, 2014 $268.21K
Current Assets Q1 2015 · Mar 31, 2015 $179.1K
Current Assets Q1 2015 · Dec 31, 2014 $322.93K
Total Assets Q1 2015 · Mar 31, 2015 $190.21K
Total Assets Q1 2015 · Dec 31, 2014 $331.82K
Capex Q1 2015 · Mar 31, 2014 $2.35K
Operating Cash Flow Q1 2015 · Mar 31, 2014 −$180.42K
Cash And Equivalents Q1 2015 · Mar 31, 2014 $502.8K
Cash And Equivalents Q1 2015 · Dec 31, 2013 $18.99K
Sga Expense Q1 2015 · Mar 31, 2014 $176.36K
Rd Expense Q1 2015 · Mar 31, 2014 $14.23K
Net Income Q1 2015 · Mar 31, 2014 −$192.46K
Operating Income Q1 2015 · Mar 31, 2014 −$191.33K